Semaglutide 2 mg/vial
Semaglutide 2 mg Packaging: 1 vial Manufacturer: Hilma
Description
Semaglutide is a GLP-1 receptor agonist (GLP-1 analog) with 94% homology to human GLP-1. It works by activating GLP-1 receptors, helping regulate blood glucose levels through glucose-dependent insulin secretion and suppression of glucagon. It also slows gastric emptying, reducing post-meal glucose spikes and appetite.
Its prolonged action is achieved through strong binding to albumin, which reduces renal clearance and protects against metabolic degradation. Structural modifications also enhance resistance to DPP-4 enzyme breakdown.
Specifications
Drug type: injectable peptide (GLP-1 receptor agonist)
Administration: parenteral (injection)
Mechanism: increases insulin secretion, reduces glucagon, slows gastric emptying
Half-life: long-acting (once-weekly dosing)
Molecular weight: 4113.58 g/mol
Composition / properties
Form: injectable vial
Dose: 2 mg per vial
Active substance: semaglutide
Manufacturer: Hilma
Category: injectable GLP-1 analogs
Product FAQ
Quality Control:
Purity: ≥99%
Endotoxin level: <0.03 EU/mg
Authenticity verification via scratch code on each box
Key Effects:
Reduces fasting and postprandial blood glucose levels
Enhances insulin secretion (glucose-dependent)
Lowers glucagon levels
Slows gastric emptying
Supports appetite control and weight management
Dosing Guide:
Weeks 1–4: 0.25 mg/week
Weeks 5–8: 0.5 mg/week
Increase to 1 mg/week if well tolerated
Reviews
Leave a review